Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
批准号:
10667803
负责人:
Sanjay Rajagopalan
金额:
$79.92万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-15 至 2027-02-28
关键词:
AdherenceAdipose tissueAfrican American populationAgatston ScoreAgeAgonistAnticoagulantsAortaArchivesAtherosclerosisBig DataBlood PlateletsBlood VesselsBrown FatCadaverCalciumCardiometabolic DiseaseCardiovascular DiseasesCardiovascular systemCause of DeathChargeChestClassificationClinicalClinical DataClinical TrialsCohort StudiesComputer softwareCoronaryCoronary Artery Risk Development in Young Adults StudyCoronary arteryCounselingDataData ReportingData SetDecision MakingDiabetes MellitusDiseaseElasticityEngineeringEvaluationEventFatty acid glycerol estersFutureGCG geneGenesGroupingHeartHeart DiseasesHepaticImageIndividualInferiorInflammationInstitutionKnowledgeLinkMachine LearningMediastinalMetabolicMethodologyMethodsModelingMorphologyObesityOncologyParticipantPathologicPatientsPharmaceutical PreparationsPhenotypePreventive therapyPsoriasisRaceRecommendationReproducibilityResearchRiskRisk FactorsRisk MarkerRoleScanningScreening procedureShapesSiteSocioeconomic StatusSurfaceTechnology TransferTestingTextureTherapeuticTissuesUniversity HospitalsWorkX-Ray Computed Tomographyabdominal fatartificial intelligence methodcalcificationcardioprotectioncardiovascular disorder riskcardiovascular risk factorclinical riskcohortcommercializationcomorbiditycoronary artery calcificationcostdata repositorydeep learningdensitydisease phenotypedosagehigh riskimaging modalityimprovedinhibitorinnovationinterestlarge datasetsmetabolomicsneural networknovelpersonalized medicineprogramsradiomicsresearch studyrisk predictionrisk stratificationside effectsocioeconomicsstatisticssuccesstime use
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
Summary
Using a comprehensive machine learning analysis of coronary artery calcifications and thoracic fat depots in
CT calcium score images, we will predict future major adverse cardiovascular events. Improved characteriza-
tion of cardiovascular risk will advance knowledge of cardiometabolic disease phenotypes and support clinical
therapeutic decision-making and patient counseling for improved adherence. With improved risk prediction and
identification of high-risk phenotypes, there will be an opportunity to guide precision preventive therapies,
where guidance is needed given the cost and side effects associated with some of these therapies. The Agat-
ston calcium score is the leading predictor of a future major adverse cardiovascular event, better than any oth-
er single assessment. Epicardial fat volume and HU values are independent risk factors. We will combine
analyses of fat and calcifications in CT calcium score exams in an unprecedented way. For coronary calcifica-
tions, pathological observations and preliminary results suggest that examining other features (calcium-omics)
can improve prediction as compared to whole-heart Agatston. Our assessments will characterize small, spotty,
low-density calcifications, providing a better surrogate of disease vulnerability than Agatston, which is numeri-
cally dominated by large, likely stable, calcifications. In addition to fat volumes, we will examine quantitative
texture and shape features (fat-omics). Elevated HU values and tissue textures are indicative of fat inflamma-
tion. All these observations suggest significant value in a combined fat-omics and calcium-omics analysis. We
will use large archives of CT calcium score exams from different sites, including University Hospitals of Cleve-
land, which is an institution with the largest no-charge CT calcium scoring program (>13,000 scans per year).
These big data repositories provide a unique machine-learning opportunity. Numerous technical innovations
are planned, including novel features, data representations, and machine learning approaches. In addition to
clinical risk prediction, our CT calcium score analyses will dovetail in the future with many research interests,
including the role of genes, metabolomics, co-morbidities (e.g., diabetes and psoriasis), socio-economic status,
and cardio-oncology on cardiovascular risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
-
批准号:10853742
-
项目类别:
-
资助金额:$76.76万
-
财政年份:2023
-
负责人:Sanjay Rajagopalan
-
依托单位:
Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CT
-
批准号:10577558
-
项目类别:
-
资助金额:$78.61万
-
财政年份:2023
-
负责人:Sanjay Rajagopalan
-
依托单位:
Diversity Suppplement (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
-
批准号:10675939
-
项目类别:
-
资助金额:$6.26万
-
财政年份:2023
-
负责人:Sanjay Rajagopalan
-
依托单位:
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
-
批准号:10862217
-
项目类别:
-
资助金额:$12.03万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
-
批准号:10653695
-
项目类别:
-
资助金额:$96.04万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
ACHIEVE P3 - CHD
-
批准号:10494208
-
项目类别:
-
资助金额:$58.51万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
-
批准号:10170987
-
项目类别:
-
资助金额:$96.04万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
-
批准号:10452498
-
项目类别:
-
资助金额:$96.04万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
ACHIEVE P3 - CHD
-
批准号:10437398
-
项目类别:
-
资助金额:$87.19万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
ACHIEVE P3 - CHD
-
批准号:10662514
-
项目类别:
-
资助金额:$92.04万
-
财政年份:2021
-
负责人:Sanjay Rajagopalan
-
依托单位:
Transcultural lessons in the Management of Heart Failure TRANSMEDHF
-
批准号:9767262
-
项目类别:
-
资助金额:$12.0万
-
财政年份:2018
-
负责人:Sanjay Rajagopalan
-
依托单位:
EXercise MRI evaluation of HIV-PAH Longitudinal Determinants (EXHALTED)
-
批准号:9420374
-
项目类别:
-
资助金额:$59.76万
-
财政年份:2017
-
负责人:Sanjay Rajagopalan
-
依托单位:
MINERALOCORTICOID RECEPTOR ANTAGONISM CLINICAL EVALUATION IN ATHEROSOCLEROSIS (MAGMA)
-
批准号:9404108
-
项目类别:
-
资助金额:$62.85万
-
财政年份:2016
-
负责人:Sanjay Rajagopalan
-
依托单位:
Environmental Triggers of Cardiometabolic Disease
-
批准号:8600679
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2011
-
负责人:Sanjay Rajagopalan
-
依托单位:
Environmental Triggers of Cardiometabolic Disease
-
批准号:8223143
-
项目类别:
-
资助金额:$42.43万
-
财政年份:2011
-
负责人:Sanjay Rajagopalan
-
依托单位:
Environmental Triggers of Cardiometabolic Disease
-
批准号:9428010
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2011
-
负责人:Sanjay Rajagopalan
-
依托单位:
Environmental Triggers of Cardiometabolic Disease
-
批准号:8027163
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2011
-
负责人:Sanjay Rajagopalan
-
依托单位:
Environmental Triggers of Cardiometabolic Disease
-
批准号:8404015
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2011
-
负责人:Sanjay Rajagopalan
-
依托单位:
Multivalent Theranostics for Inflammation
-
批准号:8204410
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2010
-
负责人:Sanjay Rajagopalan
-
依托单位:
Diet-Environment Interactions in Inflammation
-
批准号:8839541
-
项目类别:
-
资助金额:$35.81万
-
财政年份:2010
-
负责人:Sanjay Rajagopalan
-
依托单位:
海外基金